These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enhanced in Vivo Blood-Brain Barrier Penetration by Circular Tau-Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy. Li X; Yang Y; Zhao H; Zhu T; Yang Z; Xu H; Fu Y; Lin F; Pan X; Li L; Cui C; Hong M; Yang L; Wang KK; Tan W J Am Chem Soc; 2020 Feb; 142(8):3862-3872. PubMed ID: 31991082 [TBL] [Abstract][Full Text] [Related]
3. VHHs as tools for therapeutic protein delivery to the central nervous system. Wouters Y; Jaspers T; Rué L; Serneels L; De Strooper B; Dewilde M Fluids Barriers CNS; 2022 Oct; 19(1):79. PubMed ID: 36192747 [TBL] [Abstract][Full Text] [Related]
4. Delivery of beta-galactosidase to mouse brain via the blood-brain barrier transferrin receptor. Zhang Y; Pardridge WM J Pharmacol Exp Ther; 2005 Jun; 313(3):1075-81. PubMed ID: 15718287 [TBL] [Abstract][Full Text] [Related]
5. Truncation and Mutation of a Transferrin Receptor Aptamer Enhances Binding Affinity. Macdonald J; Houghton P; Xiang D; Duan W; Shigdar S Nucleic Acid Ther; 2016 Dec; 26(6):348-354. PubMed ID: 27500826 [TBL] [Abstract][Full Text] [Related]
6. G-Quadruplex-Proximized Aptamers (G4PA) Efficiently Targeting Cell-Surface Transferrin Receptors for Targeted Cargo Delivery. Du Y; Wang Q; Shi L; Li T Nano Lett; 2022 Aug; 22(15):6328-6333. PubMed ID: 35900277 [TBL] [Abstract][Full Text] [Related]
7. Advanced translational PBPK model for transferrin receptor-mediated drug delivery to the brain. Sato S; Liu S; Goto A; Yoneyama T; Okita K; Yamamoto S; Hirabayashi H; Iwasaki S; Kusuhara H J Control Release; 2023 May; 357():379-393. PubMed ID: 37031741 [TBL] [Abstract][Full Text] [Related]
8. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity. Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588 [TBL] [Abstract][Full Text] [Related]
9. Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Wiley DT; Webster P; Gale A; Davis ME Proc Natl Acad Sci U S A; 2013 May; 110(21):8662-7. PubMed ID: 23650374 [TBL] [Abstract][Full Text] [Related]
10. Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Clark AJ; Davis ME Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12486-91. PubMed ID: 26392563 [TBL] [Abstract][Full Text] [Related]
11. A DNA Aptameric Ligand of Human Transferrin Receptor Generated by Cell-SELEX. Zhang N; Bing T; Shen L; Feng L; Liu X; Shangguan D Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445629 [TBL] [Abstract][Full Text] [Related]
12. Targeting the transferrin receptor for brain drug delivery. Johnsen KB; Burkhart A; Thomsen LB; Andresen TL; Moos T Prog Neurobiol; 2019 Oct; 181():101665. PubMed ID: 31376426 [TBL] [Abstract][Full Text] [Related]
13. Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo. Johnsen KB; Bak M; Melander F; Thomsen MS; Burkhart A; Kempen PJ; Andresen TL; Moos T J Control Release; 2019 Feb; 295():237-249. PubMed ID: 30633947 [TBL] [Abstract][Full Text] [Related]
14. Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood-Brain Barrier Sonopermeation. Dasgupta A; Sun T; Rama E; Motta A; Zhang Y; Power C; Moeckel D; Fletcher SM; Moosavifar M; Barmin R; Porte C; Buhl EM; Bastard C; Pallares RM; Kiessling F; McDannold N; Mitragotri S; Lammers T Adv Mater; 2023 Dec; 35(52):e2308150. PubMed ID: 37949438 [TBL] [Abstract][Full Text] [Related]
15. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes. Johnsen KB; Moos T J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072 [TBL] [Abstract][Full Text] [Related]
16. In Vivo Use of a Multi-DNA Aptamer-Based Payload/Targeting System To Study Dopamine Dysregulation in the Central Nervous System. McConnell EM; Ventura K; Dwyer Z; Hunt V; Koudrina A; Holahan MR; DeRosa MC ACS Chem Neurosci; 2019 Jan; 10(1):371-383. PubMed ID: 30160936 [TBL] [Abstract][Full Text] [Related]
17. Aptamer Nanoconstructs Crossing Human Blood-Brain Barrier Discovered via Microphysiological System-Based SELEX Technology. Choi JW; Seo M; Kim K; Kim AR; Lee H; Kim HS; Park CG; Cho SW; Kang JH; Joo J; Park TE ACS Nano; 2023 May; 17(9):8153-8166. PubMed ID: 37068137 [TBL] [Abstract][Full Text] [Related]
18. Gene therapy targeting the blood-brain barrier. Körbelin J; Arrulo A; Schwaninger M Vitam Horm; 2024; 126():191-217. PubMed ID: 39029973 [TBL] [Abstract][Full Text] [Related]
19. The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain. Sharma G; Lakkadwala S; Modgil A; Singh J Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231900 [TBL] [Abstract][Full Text] [Related]